Skip to content

study the effect of ayurvedic marma therapy in cases of severe headache with clinical symptoms.

Randomized control study on effect of apanga marma therapy in cases of migraine with aura

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/053342
Enrollment
60
Registered
2023-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R42- Dizziness and giddiness

Interventions

None listed

Sponsors

Banaras Hindu University
Lead Sponsor
Dr Abhishek Pathak
Collaborator
Prof H H Awasthi
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1 Meeting the International Classification of Headache Disorders-3 (ICHD-3) criteria for Chronic Migraine with aura 2 Headache history > 3 months 3 Willing to complete daily diary 4 Willing to take the Marma Therapy for 90 days

Exclusion criteria

Exclusion criteria: 1 Age below 18 and above 60 years 2 Marked (moderate to severe degree) in accordance with MIDAS score. 3 Major medical illness under treatment such as Tuberculosis, Aids, Malaria, Hypertension, Diabetes mellitus etc. Migraine without aura. 4 History of Psychotic diseases 5 Use of any other alternative medication during the study period 6 Patient not willing to give his/her consent 7 Patient suffering from secondary causes of headache

Design outcomes

Primary

MeasureTime frame
Apanga marma therapy assessment on subjective parameter of Severity of headache Frequency of headache Duration of headache Nausea Vomiting Giddiness Aura Associated complaintsTimepoint: 3 month

Secondary

MeasureTime frame
Assessment of apanga marma therapy with objective parameter of Migraine Disability Assessment Score (MIDAS) Visual Analogue Scale (VAS) HEAD IMPACT TEST [HIT-6]Timepoint: 3 month

Countries

India

Contacts

Public ContactSakshi Surve

Banaras Hindu University

survesakshi02@gmail.com9594914770

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026